Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 0 | 0 | 0 | 0 | 69 |
| Gross Profit | N/A | N/A | N/A | N/A | 499 |
| Operating Expenses | 2,788 | 871 | 805 | 1,464 | 298 |
| Operating Income | -2,788 | -871 | -805 | -1,464 | -229 |
| Other Income | -19 | -159 | -761 | -759 | -126 |
| Pre-tax Income | -2,807 | -1,030 | -1,566 | -2,223 | -354 |
| Net Income Continuous | -2,807 | -1,030 | -1,566 | -2,223 | -354 |
| Net Income Discontinuous | -378 | -68 | -114 | 37 | N/A |
| Net Income | $-3,185 | $-1,098 | $-1,680 | $-2,186 | $-870 |
| EPS Basic Total Ops | -874.13 | -349.65 | -524.48 | -786.71 | -437.06 |
| EPS Basic Continuous Ops | -699.30 | -349.65 | -524.48 | -786.71 | -199.66 |
| EPS Basic Discontinuous Ops | -130.75 | -21.16 | -35.74 | 12.82 | N/A |
| EPS Diluted Total Ops | -874.13 | -349.65 | -524.48 | -786.71 | -437.06 |
| EPS Diluted Continuous Ops | -699.30 | -349.65 | -524.48 | -786.71 | -196.47 |
| EPS Diluted Discontinuous Ops | -130.75 | -21.16 | -35.74 | 12.82 | N/A |
| EBITDA(a) | $-2,720 | $-839 | $-784 | $-1,384 | $-154 |